PAIN (Pain AI iNtervention) Platform for Patients at Home
NCT05474274 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2025-12-22
Summary
The purpose of this research is to identify physiological markers to determine pain intensity and build an Artificial Intelligence (AI) enabled system to objectively measure pain intensity. Researchers hope to personalize pain medication regimens to help prevent medication over-use.
Conditions
Interventions
- OTHER
-
Machine learning algorithms
Machine learning techniques to rank order physiologic variables obtained via the wearable and handheld devices as well as remove low-importance and redundant variables to accurately determine postoperative pain intensity in outpatients
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Antonio Forte, MD, PhD · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-23
- Primary Completion
- 2026-11-30
- Completion
- 2027-11-30
Countries
- United States
Study Locations
More Related Trials
-
Self-Management of Chronic Pain
NCT04837794 ·Status: COMPLETED
-
Quantitative SSEP and EEG As Objective Pain Biomarker
NCT03495180 ·Status: WITHDRAWN ·Phase: NA
-
Optimizing Chronic Pain Treatment With Enhanced Neuroplastic Responsiveness
NCT02681081 ·Status: COMPLETED ·Phase: NA
-
Low Dose Naltrexone (LDN) Immune Monitoring
NCT02107014 ·Status: COMPLETED ·Phase: NA
-
Patient-Centered Chronic Pain Care
NCT05256394 ·Status: COMPLETED ·Phase: NA
-
Effectiveness Pain Neuroscience Education In The Executive Functions In Patients With Fibromyalgia
NCT05084300 ·Status: UNKNOWN ·Phase: NA
-
Analysis of Facial Expressions for Pain Recognition in Fibromyalgia: Using Artificial Intelligence and Biomarkers
NCT06813352 ·Status: RECRUITING
-
Mindfulness Intervention for Fibromyalgia Delivered Through a Smartphone App
NCT07032519 ·Status: COMPLETED ·Phase: NA
-
Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism?
NCT02806440 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing Central Aspects of Pain
NCT06518278 ·Status: RECRUITING
-
"SMART-FM": Smart-Phone Based Digital Therapeutic for Management of Fibromyalgia
NCT05005351 ·Status: COMPLETED ·Phase: PHASE2
-
Sleep and Pain Interventions in Fibromyalgia
NCT02001077 ·Status: COMPLETED ·Phase: NA
-
Predictive Models on Pain and Severity in FM Patients
NCT04918602 ·Status: UNKNOWN
-
Influence of Exercise Type, Pain Mechanisms, and Biopsychosocial Contributions to Pain Relief in Those With Fibromyalgia
NCT03778385 ·Status: UNKNOWN ·Phase: NA
-
Effect of Revival Soy on Fibromyalgia Pain
NCT00279942 ·Status: COMPLETED ·Phase: NA
-
Identification of Potential Biomarkers for Pain
NCT03495245 ·Status: UNKNOWN
-
Real-time Pain Monitoring in Fibromyalgia Patients
NCT03571009 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Pain Location, Pain Quality and Pain Patterns in Subjects With Chronic Pain
NCT00284245 ·Status: UNKNOWN
-
Management of Chronic Pain
NCT04865263 ·Status: COMPLETED
-
E-health for Self-Management of Chronic Pain
NCT04628650 ·Status: COMPLETED
-
Suprathreshold Pressure Pain Stimulation in Fibromyalgia
NCT04047407 ·Status: UNKNOWN
-
Lifestyle Physical Activity to Reduce Pain and Fatigue in Adults With Fibromyalgia
NCT00383084 ·Status: COMPLETED ·Phase: NA
-
Peripheral Arterial Tonometry (PAT) Evaluation of Sleep in Fibromyalgia
NCT01151163 ·Status: UNKNOWN
-
Self-regulation of Real-time fMRI Brain Activity in Chronic Pain
NCT07023523 ·Status: RECRUITING ·Phase: NA
-
Biofeedback Training to Control Pain Processing
NCT02752386 ·Status: COMPLETED ·Phase: NA